A macrophage cell model for selective metalloproteinase inhibitor design

Area of Science:

• Biochemistry
• Enzymology
• Drug Discovery

Background:

• Matrix metalloproteinases (MMPs) are zinc-dependent enzymes targeted for inhibition.
• Numerous MMP inhibitors have failed in clinical trials due to poor specificity.
• Developing selective inhibitors is essential for therapeutic success.

Purpose of the Study:

• To develop and validate a cell-based screening method for assessing metalloenzyme inhibitor selectivity.
• To compare the selectivity of various zinc-binding groups (ZBGs) and matrix metalloproteinase inhibitors (MMPis).
• To identify novel selective inhibitors for zinc metalloenzymes.

Main Methods:

• Utilized the RAW264.7 macrophage cell line for a cell-based screening assay.
• Assessed the relative activities of zinc, heme iron, and non-heme iron enzymes in the presence of inhibitors.
• Screened nine ZBGs, four established MMPis, and two novel MMPis against five metalloenzymes.

Main Results:

• Identified 2,2 -dipyridylamine (DPA) and triazacyclononane (TACN) as highly selective ZBGs for zinc metalloenzyme inhibition.
• The cell-based model accurately predicted known nonspecific interactions of common MMPis.
• The assay provided cross-reactivity information for novel MMP inhibitors.

Conclusions:

• Cell-based assays are valuable tools for designing and screening novel metalloenzyme inhibitors.
• DPA and TACN show potential for developing selective inhibitors targeting zinc metalloenzymes.
• This approach enhances the specificity assessment of MMP inhibitors in a biological context.